
pmid: 31754692
Abstract Background The present study investigated whether the frequency of sleep medication use affects subjective cognitive decline (SCD) or SCD with functional difficulties in elderly individuals. Methods The 2018 Korea Community Health Survey data, which consists of national representative and community-based data, was used in this study. A total of 57,050 individuals aged 65 years or older were included in this study. SCD was measured using the Behavioral Risk Factor Surveillance System. A logistic regression analysis was used to analyze the data. Results In total, 16,966 (29.7%) participants had SCD and 3,487 (6.1%) had SCD with functional difficulties. The elderly individuals who took sleep medication more than once a week had higher risks of both SCD and SCD with functional difficulties than those who did not take any sleep medication in a month (SCD: odds ratio [OR] = 1.329, 95% confidence interval [CI] = 1.194–1.480; SCD with functional difficulties: OR = 1.752, 95% CI = 1.491–2.058). Conclusions Frequent sleep medication use was associated with both SCD and SCD with functional difficulties. This study suggests that early detection of cognitive impairment and efforts to reduce the frequent use of sleeping pills in patients with insomnia might be helpful to reduce the burden of SCD and SCD with functional difficulties in the elderly population.
Male, Sleep Wake Disorders, 610, Behavioral Risk Factor Surveillance System, Risk Factors, Surveys and Questionnaires, Pharmaceutical / therapeutic use, 616, Activities of Daily Living, 80 and over, Humans, Cognitive Dysfunction, Aged, Aged, 80 and over, Cognitive Dysfunction / chemically induced*, Sleep Aids, Pharmaceutical, Subjective cognitive decline, Sleep medication, Female, Subjective cognitive decline-related functional difficulties, Pharmaceutical / adverse effects*, Sleep Wake Disorders / drug therapy, Sleep Aids
Male, Sleep Wake Disorders, 610, Behavioral Risk Factor Surveillance System, Risk Factors, Surveys and Questionnaires, Pharmaceutical / therapeutic use, 616, Activities of Daily Living, 80 and over, Humans, Cognitive Dysfunction, Aged, Aged, 80 and over, Cognitive Dysfunction / chemically induced*, Sleep Aids, Pharmaceutical, Subjective cognitive decline, Sleep medication, Female, Subjective cognitive decline-related functional difficulties, Pharmaceutical / adverse effects*, Sleep Wake Disorders / drug therapy, Sleep Aids
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 24 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Top 10% | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Top 10% | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Top 10% |
